Archer Aviation vs. Joby Aviation: Which eVTOL Stock Is a Better Buy in 2026?

Joby Aviation is presented as the stronger long-term eVTOL investment for 2026, supported by $53.4M of FY2025 revenue, Toyota manufacturing backing, Delta Air Lines investment, and progress toward final FAA verification. Archer generated only about $300,000 of FY2025 revenue and posted a $618.2M net loss, versus Joby's $929.8M loss, though Archer has lower annual cash burn and added Boeing-derived defense subsidiaries. Both remain pre-profit and cash-intensive, with negative free cash flow of $511.7M for Archer and $563.8M for Joby; Joby's 52.0x P/S ratio is substantially below Archer's 618.1x.

Analysis

The investable distinction is not near-term revenue but capital efficiency through certification and production ramp. JOBY's partner ecosystem can externalize pieces of manufacturing, demand aggregation and airport access, reducing the probability of a dilutive standalone infrastructure build; TM also has strategic incentive to protect the manufacturing learning curve. ACHR's defense optionality could diversify end-market exposure, but it also risks management distraction and working-capital volatility precisely when a single aircraft program requires tight certification and industrialization focus.

The reported sales multiples are not decision-useful at this stage: small, contract-derived revenue bases make P/S mechanically unstable, while both equities should trade on cash runway, certification milestones, production yield and forward funding needs. Over the next 1-3 months, FAA verification progress, flight-test interruptions, partner capital commitments and any equity issuance are the principal catalysts. Over 6-18 months, the first credible evidence of repeatable aircraft production—not announcements of routes or partnerships—will determine which company earns a platform/manufacturing premium versus being repriced as a capital-consuming aerospace development program.

Consensus may be underpricing correlation between the two names: a safety event, FAA process change, battery-performance issue, or public acceptance setback would compress the entire eVTOL complex, regardless of relative execution. Conversely, the market may be over-crediting announced strategic relationships; airline and automotive partners provide validation but are not equivalent to irrevocable fleet purchases or committed project financing. The claimed Boeing-related transaction and scope of acquired operations should be verified against SEC filings before assigning ACHR defense revenue or backlog value; if not consolidated or not cash-generative, the apparent diversification thesis is materially weaker.

Key Decisions for Investors

• Initiate a modest 3-6 month pair: long JOBY / short ACHR, sized beta-neutral and limited to 50-75 bps gross NAV initially. The thesis is relative execution and funding quality, not sector direction; target a 15-25% relative move, with a stop if ACHR demonstrates independently verified defense backlog/cash generation or JOBY discloses a material certification delay.
• Do not underwrite either name from P/S. Build a quarterly dashboard of unrestricted cash, operating cash burn, committed versus aspirational partner funding, aircraft production rate, and FAA milestone completion; downgrade both on a cash-runway deterioration toward less than 18 months absent clearly priced financing.
• Use BA and TM as higher-quality watch-list expressions rather than direct eVTOL substitutes. A verified increase in Boeing exposure to ACHR-related defense operations could modestly improve BA's optionality but is unlikely to move consolidated earnings; TM is the more relevant read-through on JOBY manufacturing credibility, though any equity impact should remain immaterial without volume commitments.
• Avoid directional long exposure into binary certification announcements unless options implied volatility offers favorable asymmetric structures and liquidity is adequate. A broad regulatory or safety setback would likely produce simultaneous drawdowns in JOBY and ACHR, making the relative-value pair preferable to outright exposure.